Effect of Waon therapy on oxidative stress in chronic heart failure

Circulation Journal

Volumn 75, Issue 2, 2011, Pages 348-356

  Fujita, Shoji ^a   Ikeda, Yoshiyuki ^a   Miyata, Masaaki ^a   Shinsato, Takuro ^a   Kubozono, Takuro ^a   Kuwahata, So ^a   Hamada, Narisato ^a   Miyauchi, Takahiro ^a   Yamaguchi, Tsuyoshi ^b   Torii, Hiroyuki ^b   Hamasaki, Shuichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima City Hospital   (Japan)

Author keywords

Heart failure; Heat shock protein; Oxidative stress; Waon therapy

Indexed keywords

4 HYDROXYNONENAL; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ACTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 32; HYDROPEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HAMSTER; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HUMAN; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION; WAON THERAPY; WESTERN BLOTTING;

AGED; ALDEHYDES; ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HEAT-SHOCK PROTEINS; HOT TEMPERATURE; HUMANS; HYDROGEN PEROXIDE; INFRARED RAYS; MALE; MESOCRICETUS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 79251536219     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0630     Document Type: Article

References (51)

1. Tei C. Waon therapy: Soothing warmth therapy. J Cardiol 2007; 49: 301 - 304.
2. Tei C, Horikiri Y, Park JC, Jeong JW, Chang KS, Toyama Y, et al. Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation 1995; 91: 2582 - 2590.
3. Tei C, Tanaka N. Thermal vasodilation as a treatment of congestive heart failure: A novel approach. J Cardiol 1996; 27: 29-30.
4. Kihara T, Biro S, Imamura M, Yoshifuku S, Takasaki K, Ikeda Y, et al. Repeated thermal therapy treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 754-759.
5. Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, Masuda A, et al. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 2004; 68: 1146-1151.
6. Miyata M, Kihara T, Kubozono T, Ikeda Y, Shinsato T, Izumi T, et al. Beneficial effects of Waon therapy on patients with chronic heart failure: Results of a prospective multicenter study. J Cardiol 2008; 52: 79-85.
7. Basford JR, Oh JK, Allison TG, Sheffield CG, Manahan BG, Hodge DO, et al. Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: A pilot report. Arch Phys Med Rehabil 2009; 90: 173-177.
8. Kihara T, Miyata M, Fukudome T, Ikeda Y, Shinsato T, Kubozono T, et al. Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol 2009; 53: 214-218.
9. st century. Circ J 2010; 74: 617-621.
10. Tei C, Shinsato T, Miyata M, Kihara T, Hamasaki S. Waon therapy improves peripheral arterial disease. J Am Coll Cardiol 2007; 50: 2169-2171.
11. Tei C, Shinsato T, Kihara T, Miyata M. Successful thermal therapy for end-stage peripheral artery disease. J Cardiol 2006; 47: 163-164.
12. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, et al. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 2001; 38: 1083-1088.
13. Masuda A, Miyata M, Kihara T, Minagoe S, Tei C. Repeated sauna therapy reduces urinary 8-epi-prostaglandin F (2alpha). Jpn Heart J 2004; 45: 297-303.
14. Ikeda Y, Biro S, Kamogawa Y, Yosifuku S, Eto H, Orihara K, et al. Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. Circ J 2005; 69: 722-729.
15. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and mitochondrial DNA damage in heart failure. Circ J 2008; 72(Suppl A): A-31-A-37.
16. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991; 65: 245-248.
17. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure. Circulation 1998; 97: 1536-1539.
18. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998; 31: 1352-1356.
19. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 97: 363-368.
20. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002; 105: 2867-2871.
21. Nickenig G. Should angiotensin II receptor blockers and statins be combined? Circulation 2004; 110: 1013-1020.
22. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114: 2508-2516.
23. Kato Y, Iwase M, Ichihara S, Kanazawa H, Hashimoto K, Noda A, et al. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters. Circ J 2010; 74: 163-170.
24. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, et al. Antioxidative effects of exercise training in patients with chronic heart failure: Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111: 1763-1770.
25. Mantovani G, Macciò A, Madeddu C, Mura L, Massa E, Gramignano G, et al. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: Impact of an antioxidant treatment. J Cell Mol Med 2002; 6: 570-582.
26. Shimano M, Shibata R, Inden Y, Yoshida N, Uchikawa T, Tsuji Y, et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 2009; 6: 935-940.
27. 15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
28. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 1982; 66: 342-354.
29. Ichihara S, Yamada Y, Ichihara G, Kanazawa H, Hashimoto K, Kato Y, et al. Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy. Biochem Biophys Res Commun 2006; 350: 105-113.
30. Yu B, Otsuji Y, Yoshifuku S, Ikeda Y, Kamogawa Y, Yuasa T, et al. Prediction of prognosis in the UM-X7.1 hamster model of congestive heart failure using the Tei index. Circ J 2005; 69: 991-993.
31. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, et al. The monoclonal antibody specific for the 4-hydroxy-2- nonenal histidine adduct. FEBS Lett 1995; 359: 189-191.
32. Maki RA, Tyurin VA, Lyon RC, Hamilton RL, DeKosky ST, Kagan VE, et al. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem 2009; 284: 3158-3169.
33. Ilangovan G, Venkatakrishnan CD, Bratasz A, Osinbowale S, Cardounel AJ, Zweier JL, et al. Heat shock-induced attenuation of hydroxyl radical generation and mitochondrial aconitase activity in cardiac H9c2 cells. Am J Physiol Cell Physiol 2006; 290: C313-C324.
34. Turakhia S, Venkatakrishnan CD, Dunsmore K, Wong H, Kuppusamy P, Zweier JL, et al. Doxorubicin-induced cardiotoxicity: Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol 2007; 293: H3111-H3121.
35. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 1786-1795.
36. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: Anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 1999; 41: 385-394.
37. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
38. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996; 78: 58-64.
39. Katz SD. Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 1997; 12: 259-264.
40. Ferrari R, Bachetti T, Agnoletti L, Comini L, Curello S. Endothelial function and dysfunction in heart failure. Eur Heart J 1998; 19: G41-G47.
41. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: Role of tumor necrosis factor-alpha. Circulation 1999; 100: 1983-1991.
42. Fukai T. Endothelial GTPCH in eNOS uncoupling and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 1493-1495.
43. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
44. Liu L, Zhang X, Qian B, Min X, Gao X, Li C, et al. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Eur J Heart Fail 2007; 9: 762-769.
45. Yoshida T, Maulik N, Ho YS, Alam J, Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 2001; 103: 1695-1701.
46. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89: 168-173.
47. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, Hori M. Involvement of cytokines in the mechanism of whole-body hyperthermia- induced cardioprotection. Circulation 2000; 102: 452-457.
48. Lee YJ, Cho HN, Jeoung DI, Soh JW, Cho CK, Bae S, et al. HSP25 overexpression attenuates oxidative stress-induced apoptosis: Roles of ERK1/2 signaling and manganese superoxide dismutase. Free Radic Biol Med 2004; 36: 429-444.
49. Banerjee Mustafi S, Chakraborty PK, Dey RS, Raha S. Heat stress upregulates chaperone heat shock protein 70 and antioxidant manganese superoxide dismutase through reactive oxygen species (ROS), p38MAPK, and Akt. Cell Stress Chaperones 2009; 14: 579-589.
50. Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 2009; 73: 201-207.
51. Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, et al. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997; 17: 3191-3195.